-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Lineage Cell Therapeutics, Inc. quarterly Costs and Expenses history and growth rate from 2023 to 2024.
- Lineage Cell Therapeutics, Inc. Costs and Expenses for the quarter ending March 31, 2024 was $8.11 M, a 10.2% decline year-over-year.
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)